Kaiser Khan
Editorial Director · World Aid Network
About Kaiser Khan & Editorial Mission
Kaiser Khan serves as Editorial Director for Breast Cancer Charity, a specialized health education and international screening initiative founded by World Aid Network, London. Kaiser oversees all content production, technical search specifications, machine-legibility standards, and editorial compliance across the platform.
With extensive experience in open-data publishing, digital strategy, and health communication, Kaiser ensures that every article, clinical guide, and financial disclosure published on breastcancer-charity.org meets stringent standards of clarity, medical accuracy, and public trust.
Health Information Desk-Assessment Methodology
Under Kaiser's direction, all clinical content — covering breast cancer symptoms, Touch–Look–Check (TLC) self-examinations, mammography schedules, disease staging, and treatment side effects — undergoes a rigorous desk-assessment workflow:
- Primary Source Verification: All medical claims are verified directly against authoritative primary guidance from NHS.uk, National Institute for Health and Care Excellence (NICE), Cancer Research UK, and World Health Organization (WHO) IARC monographs.
- Zero-Fabrication Discipline: No medical statistics, treatment outcomes, survival rates, or cost figures are invented. If data is unavailable or uncertain, it is explicitly disclosed as unknown.
- Question-Shaped Clarity: Health topics are formatted into direct, extractable 40–60-word answers that give readers immediate clarity before providing in-depth medical context.
- Clear Scope Disclaimers: Every clinical guide explicitly states who the content is NOT for — clarifying that online guides provide public health education, not personal clinical diagnosis or NHS appointment bookings.
Fundraising Transparency & Governance Standard
Kaiser enforces a strict separation between fundraising communications and clinical content. Key governance rules include:
- Honest Registration Status: Full disclosure of Charity Commission registration status (application reference 5290505) and parent entity details (World Aid Network, ICO ZC156579).
- Unit Cost Verification: Programmatic unit costs (£25 screening, £75 biopsy, £150 hormone therapy support) are itemized and published in Open Knowledge Format (OKF) data packages.
- Corrections Policy: All public feedback or factual corrections are logged, reviewed, and updated in our public corrections registry.
Editorial Disclaimers & Contact
This author profile verifies editorial oversight for breastcancer-charity.org. It does not assert personal clinical registration or medical license.